MindMaze Raises $105M To Advance Mixed-Reality Brain Health Tech
Digital neurotherapeutics company MindMaze plans to use the new funding to ramp up commercialization and expand its footprint in the US, also aided by a new partnership with the American Hospital Association.
You may also be interested in...
Digital Health Roundup: Exec Chats With Illumina, Bloom, AngelMed; M&A, Funding; FDA Down-Classifies Apps
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights IBM Watson Health’s divestiture and other financing news, Exec Chats with Illumina, AngelMed and Bloom, Philips’ new hand-held ultrasound device and autonomous robotic surgery, as well as the latest FDA news on digital health.
Akili Interactive, which developed a video game to treat ADHD, will go public with one of Palihapitiya’s blank-check companies. The proceeds will be used to launch the FDA-cleared EndeavorRx digital therapeutics.
MindMaze, which designs VR-based games to help people retore motor function after stroke or brain injury, will use the proceeds to accelerate marketing of its platform and run clinical trials.